BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Vries TAC, Hirsh J, Xu K, Mallick I, Bhagirath VC, Eikelboom JW, Ginsberg JS, Kruger PC, Chan NC. Apixaban for Stroke Prevention in Atrial Fibrillation: Why are Event Rates Higher in Clinical Practice than in Randomized Trials?—A Systematic Review. Thromb Haemost 2020;120:1323-9. [DOI: 10.1055/s-0040-1713889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Chao TF, Potpara TS. Long-Term Effects of Apixaban Confirmed in the Open-Label Extension of AVERROES Trial. Thromb Haemost 2021;121:405-7. [PMID: 33472253 DOI: 10.1055/a-1367-0184] [Reference Citation Analysis]
2 Lee SR, Choi EK, Park SH, Jung JH, Han KD, Oh S, Lip GYH. Off-label underdosed apixaban use in Asian patients with non-valvular atrial fibrillation. Eur Heart J Cardiovasc Pharmacother 2021:pvab004. [PMID: 33471125 DOI: 10.1093/ehjcvp/pvab004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Bayer V, Kotalczyk A, Kea B, Teutsch C, Larsen P, Button D, Huisman MV, Lip GYH, Olshansky B. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry. J Am Heart Assoc 2022;:e023907. [PMID: 35243870 DOI: 10.1161/JAHA.121.023907] [Reference Citation Analysis]
4 Lee SR, Choi EK. Nonvitamin K Antagonist Oral Anticoagulants in Patients with Extreme Body Weights: One Size Fits All? Thromb Haemost 2021;121:115-7. [PMID: 33086398 DOI: 10.1055/s-0040-1718413] [Reference Citation Analysis]
5 Weber C, Rigby A, Lip GYH. Thrombosis and Haemostasis 2021 Editors' Choice Papers. Thromb Haemost 2022;122:163-70. [PMID: 35038760 DOI: 10.1055/s-0041-1741072] [Reference Citation Analysis]
6 Bhagirath VC, Chan N, Hirsh J, Ginsberg J, de Vries TA, Eikelboom J. Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose. Journal of the American College of Cardiology 2020;76:2906-7. [DOI: 10.1016/j.jacc.2020.09.615] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Rivera-Caravaca JM, Nielsen PB, Lip GYH. Should we make the risk stratification process more complex in patients with atrial fibrillation? Europace 2021;23:978. [PMID: 33532824 DOI: 10.1093/europace/euab007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Esteve-Pastor MA, Rivera-Caravaca JM, Ruiz-Ortiz M, Muñiz J, Roldán-Rabadán I, Otero D, López-Gálvez R, Cequier Á, Bertomeu-Martínez V, Badimón L, Anguita M, Lip GYH, Marín F; FANTASIIA investigators. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: Effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry. Expert Opin Pharmacother 2022. [PMID: 35924672 DOI: 10.1080/14656566.2022.2109961] [Reference Citation Analysis]
9 Menichelli D, Del Sole F, Di Rocco A, Farcomeni A, Vestri A, Violi F, Pignatelli P, Lip GYH, Pastori D. Real-world safety and efficacy of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 605 771 patients. Eur Heart J Cardiovasc Pharmacother 2021;7:f11-9. [PMID: 33493255 DOI: 10.1093/ehjcvp/pvab002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
10 de Vries TA, Hirsh J, Bhagirath VC, Ginsberg JS, Pisters R, Hemels ME, de Groot JR, Eikelboom JW, Chan NC. Can a Single Measurement of Apixaban Levels Identify Patients at Risk of Overexposure? A Prospective Cohort Study. TH Open 2022;06:e10-7. [DOI: 10.1055/s-0041-1740492] [Reference Citation Analysis]
11 Pandey AK, Eikelboom JW. Direct Oral Anticoagulant Dosing in Extremes of Body Weight: Time to Revisit the Guidelines? Thromb Haemost 2021;121:118-20. [PMID: 32942314 DOI: 10.1055/s-0040-1716753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]